The panel also verified the patient’s autoimmune history for SS, RA, and SLE based on positive serology for anti-SSA/Ro antibodies, anti-CCP antibodies, and speckled ANA, respectively. This evidence concerns the gene BTG3 and rheumatoid arthritis.